Several firms are allegedly involved in the manufacturing of Abacavir Sulphate, identified by the API number 188062-50-2, within the capital of Afghanistan . Though the operation of these concerns, verifiable information regarding their capacity and adherence to international pharmaceutical standards remain scarce . The regional pharmaceutical mark